Arax Advisory Partners’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-628
Closed -$2.03K 3096
2025
Q1
$2.03K Buy
+628
New +$2.03K ﹤0.01% 2066